ANPEP and neoplasm: In our studies, when the efficacy of bestatin was investigated, we found that this competitive inhibitor of APN/CD13 exerted its antitumor effect in both investigated tumors, where the tumor size and the APN/CD13 receptor expression decreased compared to control-untreated tumors (Figures 1 and 4).